Glucose Outcomes with the In-Home Use of a Hybrid Closed-Loop Insulin Delivery System in Adolescents and Adults with Type 1 Diabetes-Reference-Cited by-同舟云学术

Glucose Outcomes with the In-Home Use of a Hybrid Closed-Loop Insulin Delivery System in Adolescents and Adults with Type 1 Diabetes

Published:2017-03 Issue:3 Volume:19 Page:155-163
ISSN:1520-9156
Container-title:Diabetes Technology & Therapeutics
language:en
Short-container-title:Diabetes Technology & Therapeutics

Author:

Garg Satish K.¹,Weinzimer Stuart A.²,Tamborlane William V.²,Buckingham Bruce A.³,Bode Bruce W.⁴,Bailey Timothy S.⁵,Brazg Ronald L.⁶,Ilany Jacob⁷,Slover Robert H.¹,Anderson Stacey M.⁸,Bergenstal Richard M.⁹,Grosman Benyamin¹⁰,Roy Anirban¹⁰,Cordero Toni L.¹⁰,Shin John¹⁰,Lee Scott W.¹⁰,Kaufman Francine R.¹⁰

Affiliation:

1. Barbara Davis Center for Diabetes, University of Colorado Denver, Aurora, Colorado.

2. Yale University, New Haven, Connecticut.

3. Stanford University, Stanford, California.

4. Atlanta Diabetes Associates, Atlanta, Georgia.

5. AMCR Institute, Escondido, California.

6. Rainier Clinical Research Center, Renton, Washington.

7. Sheba Medical Center, Tel Hashomer, Israel.

8. University of Virginia, Charlottesville, Virginia.

9. International Diabetes Center, Minneapolis, Minnesota.

10. Medtronic, Northridge, California.

Publisher